Evidence map›Paper›PMID 21310073›Full record

ArticleBMC biochemistry2011

Bcr is a substrate for Transglutaminase 2 cross-linking activity.

Sun-Ju Yi, John Groffen, Nora Heisterkamp

Open access · hybridAbstract read
In one paragraph

Article in BMC biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sun-Ju YiSection of Molecular Carcinogenesis, Division of Hematology/Oncology, Ms#54, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles CA 90027, USA.
John Groffen
Nora Heisterkamp
Children's Hospital of Los Angeles · USUniversity of Southern California · US

Funding

TGF BETA SIGNALING IN LUNG MORPHOGENESIS, INJURY AND REPAIRP01HL060231 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 1998 to 2009
$14.5M
TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIsR01CA090321 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 2001 to 2017
$4.4M
NEGATIVE REGULATORS OF LUNG INFLAMMATIONR01HL071945 · NHLBI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI GROFFEN, JOHN H · 2003 to 2006
$1.5M
NCI NIH HHS CA090321NHLBI NIH HHS HL060231NHLBI NIH HHS HL071945
6 · The paper itself

Abstract

backgroundBreakpoint cluster region (Bcr) is a multi-domain protein that contains a C-terminal GTPase activating protein (GAP) domain for Rac. Transglutaminase 2 (TG2) regulates Bcr by direct binding to its GAP domain. Since TG2 has transglutaminase activity that has been implicated in the response to extreme stress, we investigated if Bcr can also act as a substrate for TG2.

resultsWe here report that activation of TG2 by calcium caused the formation of covalently cross-linked Bcr. Abr, a protein related to Bcr but lacking its N-terminal oligomerization domain, was not cross-linked by TG2 even though it forms a complex with it. A Bcr mutant missing the first 62 amino acid residues remained monomeric in the presence of activated TG2, showing that this specific domain is necessary for the cross-linking reaction. Calcium influx induced by a calcium ionophore in primary human endothelial cells caused cross-linking of endogenous Bcr, which was inhibited by the TG2 inhibitor cystamine. Treatment of cells with cobalt chloride, a hypoxia-mimetic that causes cellular stress, also generated high molecular weight Bcr complexes. Cross-linked Bcr protein appeared in the TritonX-100-insoluble cell fraction and further accumulated in cells treated with a proteasome inhibitor.

conclusionsBcr thus represents both an interacting partner under non-stressed conditions and a target of transglutaminase activity for TG2 during extreme stress.

Indexed as

CalciumCystamineEndothelial CellsGTPase-Activating ProteinsGTP-Binding ProteinsHumansMutationProtein BindingProtein Glutamine gamma Glutamyltransferase 2Proto-Oncogene Proteins c-bcrStress, PhysiologicalSubstrate SpecificityTransglutaminasesABR protein, humanBCR protein, humanCalciumCystamineGTPase-Activating ProteinsGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Proto-Oncogene Proteins c-bcrTransglutaminases

Identifiers

PMID21310073
PMCPMC3044668
OpenAlexW2008237037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.